BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/31/2021 12:21:18 PM | Browse: 487 | Download: 703
 |
Received |
|
2021-05-30 17:46 |
|
Peer-Review Started |
|
2021-05-30 17:49 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-11 19:05 |
|
Revised |
|
2021-06-26 13:24 |
|
Second Decision |
|
2021-12-16 03:49 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-12-22 23:31 |
|
Articles in Press |
|
2021-12-22 23:31 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-29 14:51 |
|
Publish the Manuscript Online |
|
2021-12-31 12:21 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Viral hepatitis in 2021: The challenges remaining and how we should tackle them
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rebecca Dunn, Aaron Wetten, Stuart McPherson and Mhairi C Donnelly |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mhairi C Donnelly, MBChB, Doctor, Doctor, Liver Unit, Freeman Hospital, Freeman Road
High Heaton, Newcastle NE77DN, United Kingdom. mhairi.donnelly@nhs.net |
| Key Words |
Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis E; COVID-19 |
| Core Tip |
Viral hepatitis results in 1.4 million deaths annually. The World Health Organization set an ambitious target to eliminate viral hepatitis by 2030, but significant challenges remain. These include inequalities in access to healthcare, reaching at risk populations and providing access to screening and effective treatment. In this review article, we discuss the advances in the field of viral hepatitis over the past decade. We also discuss the remaining challenges relating to viral hepatitis A to E, and suggest strategies and pathways for their resolution. |
| Publish Date |
2021-12-31 12:21 |
| Citation |
Dunn R, Wetten A, McPherson S, Donnelly MC. Viral hepatitis in 2021: The challenges remaining and how we should tackle them. World J Gastroenterol 2022; 28(1): 76-95 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i1/76.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i1.76 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
